Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ARX vs GSHD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ARX Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 5–5 Matrix Metrics)

ARX Overall Winner 6-Pillar Tally: ARX 4 – 2 GSHD Matrix Metrics: ARX 5 – 5 GSHD

As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Goosehead Insurance, Inc. (GSHD) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas GSHD carries 38.1/100 (SELL) at $48.81 (18.5x Forward P/E, 23.2% operating margin).

  • Technical & Structure Timing Caution: ARX trades in a Markup technical trend (CONSOLIDATION options phase, RSI 69.8); meanwhile GSHD is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ARX vs GSHD
ARX NYSE Head-to-Head Winner
Accelerant Holdings
Insurance Agents, Brokers & Service
$19.87
+0.1% 1D
Market Cap $4.3B
TTM Revenue $2.79B
Forward P/E 21.3x
Beta / 30D Vol -0.19β · 2% Vol
Unified Composite Score
46.9 / 100 HOLD
Tech 34.0 Fund 50.0 Flow 76.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 70
RSI-14: 69.8 · SMA20: $19.83 · SMA50: $19.80
GSHD NASDAQ
Goosehead Insurance, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$48.81
+6.09% 1D
Market Cap $1.6B
TTM Revenue $402M
Forward P/E 18.5x
Beta / 30D Vol -0.75β · 87% Vol
Unified Composite Score
38.1 / 100 SELL
Tech 30.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -13.4%) with fading momentum, RSI 49
RSI-14: 49.1 · SMA20: $49.34 · SMA50: $49.03

6-Pillar Scorecard Institutional Category Breakdown (ARX 4 – 2 GSHD)

Columns: Metric · ARX · GSHD
1. Valuation Multiples GSHD
Forward P/E 21.3x 18.5x
Trailing P/E 27.6x 33.6x
PEG Ratio N/M N/M
EV / Revenue N/M 4.1x
2. Growth & Scale ARX
Revenue Growth (YoY) +6.1% +20.7%
Earnings Growth (YoY) +800.0% +122.2%
TTM Revenue (USD) $2.79B $402M
Market Cap $4.3B $1.6B
3. Profitability & Quality GSHD
Gross Margin 62.8% 49.6%
Operating Margin 3.7% 23.2%
Net Profit Margin 5.6% 8.8%
Return on Equity (ROE) 9.2% 175.8%
4. Balance Sheet & Cash Flow ARX
Cash Generation (TTM) $634M $106M EBITDA
Cash Flow Margin 22.7% 26.3% EBITDA Mgn
Net Cash / Leverage $5.13B Net Cash 175.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ARX
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 15.7% (3rd %ile) 36.2% (3rd %ile)
Put/Call OI Skew 0.01x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat ARX
OpEx & R&D Intensity 59.1% of Rev ($1.65B) 26.4% of Rev ($106M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ARX (5) vs GSHD (5)
Institutional Metric ARX GSHD Criterion Row Edge
Market Capitalization
Scale
$4.3B $1.6B Larger Scale ARX
Trailing P/E Ratio
Valuation
27.6x 33.6x Lower Multiple ARX
Forward P/E Ratio
Valuation
21.3x 18.5x Lower Multiple GSHD
Revenue Growth (YoY)
Growth
+6.1% +20.7% Higher Growth GSHD
Operating Margin (TTM)
Profitability
3.7% 23.2% Higher Margin GSHD
Net Profit Margin
Profitability
5.6% 8.8% Higher Margin GSHD
Return on Equity (ROE)
Capital Efficiency
9.2% 175.8% Higher ROE GSHD
52-Week Range Position
Momentum
100% ($9–$20) 33% ($34–$80) Stronger Trend ARX
Beta / 30D Volatility
Risk Regime
-0.19β · 2% Vol -0.75β · 87% Vol Lower Realized Risk ARX
Unified Institutional Score
Composite Signal
46.9 / 100 (HOLD) 38.1 / 100 (SELL) Higher Composite ARX
Trailing 12M Revenue (USD)
Operating Scale
$2.79B $402M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
62.8% 49.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 4.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$634M ($5.13B Net Cash) $106M EBITDA (175.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GSHD +4.58 pp
ARX: +0.61% · GSHD: +5.19%
3M Horizon ARX +26.23 pp
ARX: +1.58% · GSHD: -24.65%
6M Horizon ARX +9.06 pp
ARX: +24.89% · GSHD: +15.83%
1Y Horizon ARX +74.82 pp
ARX: +44.4% · GSHD: -30.42%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARX vs GSHD. Trailing 12-month operating profitability (ARX 3.7% vs GSHD 23.2%) and valuation multiples (ARX 21.3x vs GSHD 18.5x Forward P/E) are benchmarked directly in Pillar 4 below.

ARX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.79B
Gross Margin62.8%
Op. Margin3.7%
ROE / Fwd P/E9.2% · 21.3x
GSHD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$402M
Gross Margin49.6%
Op. Margin23.2%
ROE / Fwd P/E175.8% · 18.5x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ARX CONSOLIDATION
50d in phase · OBV NEUTRAL
Current IV 15.7%
IV Percentile 3rd %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ARX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GSHD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 36.2%
IV Percentile 3rd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GSHD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ARX Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 3.7% operating margin.
OpEx & R&D Reinvestment 59.1% of Rev ($1.65B)
90D Engineering Disclosures 0 Published
GSHD Moat Profile High-Margin Pricing Power Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $1.6B market capitalization and 23.2% operating margin.
OpEx & R&D Reinvestment 26.4% of Rev ($106M)
90D Engineering Disclosures 0 Published

Investor FAQ ARX vs GSHD Key Questions & Quantitative Answers

As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Goosehead Insurance, Inc. (GSHD) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas GSHD carries 38.1/100 (SELL) at $48.81 (18.5x Forward P/E, 23.2% operating margin). Technical & Structure Timing Caution: ARX trades in a Markup technical trend (CONSOLIDATION options phase, RSI 69.8); meanwhile GSHD is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ARX leads the Growth & Scale pillar: ARX posts +6.1% YoY revenue growth and +800.0% YoY earnings growth on $2.79B TTM revenue (62.8% gross margin, 3.7% operating margin), compared with GSHD at +20.7% YoY revenue growth and +122.2% YoY earnings growth on $402M TTM revenue (49.6% gross margin, 23.2% operating margin). On trailing 12-month operating scale, ARX generates $2.79B in USD-normalized revenue versus $402M for GSHD. In operating R&D and SG&A reinvestment, ARX deploys 59.1% of Rev ($1.65B) (0 90-day corporate R&D disclosures) versus 26.4% of Rev ($106M) (0 disclosures) for GSHD.

GSHD screens cheaper on headline valuation multiples. ARX trades at 21.3x Forward P/E, 27.6x Trailing P/E, N/M PEG, and N/M EV/Revenue (22.7% FCF margin), whereas GSHD trades at 18.5x Forward P/E, 33.6x Trailing P/E, N/M PEG, and 4.1x EV/Revenue (26.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARX (9.2% ROE) versus GSHD (175.8% ROE) capital efficiency.

In options market volatility and institutional positioning, ARX carries 15.7% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.19β · 2% Vol realized risk). By comparison, GSHD carries 36.2% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.75β · 87% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.